UCL News


Beneficiaries of experimental gene editing therapy remain cancer-free

26 January 2017

Professor Waseem Qasim (UCL Great Ormond Street Institute of Child Health) led a team that treated two young leukaemia patients with an experimental therapy using genetically engineered immune cells from a donor. More than a year later, both girls have no sign of the leukaemia returning. Dr Simon Waddington (UCL Maternal & Fetal Medicine) comments. Read: The Independent, More: New Scientist, Reuters, The Times, Mirror